Esther Rajavelu
Stock Analyst at UBS
(0.68)
# 3,679
Out of 4,829 analysts
28
Total ratings
43.75%
Success rate
-24.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $331 → $349 | $251.15 | +38.96% | 6 | May 2, 2025 | |
| APLT Applied Therapeutics | Downgrades: Neutral | $13 → $2 | $0.40 | +400.38% | 3 | Dec 2, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $14.37 | +122.69% | 2 | Apr 9, 2024 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $35.11 | +107.92% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $20.24 | +438.54% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $9.36 | +273.93% | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $33 → $38 | $32.30 | +16.12% | 3 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $97.78 | +133.18% | 1 | Mar 1, 2021 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $1.08 | - | 2 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $13.03 | - | 1 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $13 | $18.56 | -29.94% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.46 | +584.93% | 1 | Jul 21, 2017 |
Alnylam Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $331 → $349
Current: $251.15
Upside: +38.96%
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13 → $2
Current: $0.40
Upside: +400.38%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $14.37
Upside: +122.69%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $35.11
Upside: +107.92%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $20.24
Upside: +438.54%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $9.36
Upside: +273.93%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33 → $38
Current: $32.30
Upside: +16.12%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $97.78
Upside: +133.18%
Eyenovia
Feb 3, 2020
Downgrades: Perform
Price Target: n/a
Current: $1.08
Upside: -
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $13.03
Upside: -
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $18.56
Upside: -29.94%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $1.46
Upside: +584.93%